Indusatumab vedotin
Indusatumab vedotin (pronunciation: in-du-sa-tu-mab ve-do-tin) is a type of antibody-drug conjugate used in the treatment of various types of cancer.
Etymology
The name "Indusatumab vedotin" is derived from the combination of "Indusatumab", the monoclonal antibody that targets the tissue factor, and "vedotin", the cytotoxic drug that is attached to the antibody to kill cancer cells.
Usage
Indusatumab vedotin is used in the treatment of various types of cancer, including non-small cell lung cancer, breast cancer, and gastric cancer. It works by binding to the tissue factor on the surface of cancer cells and delivering the cytotoxic drug directly to the cells, causing them to die.
Related Terms
- Antibody-drug conjugate
- Monoclonal antibody
- Tissue factor
- Cytotoxic drug
- Non-small cell lung cancer
- Breast cancer
- Gastric cancer
See Also
External links
- Medical encyclopedia article on Indusatumab vedotin
- Wikipedia's article - Indusatumab vedotin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski